A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer
Clinical trial NCT02228785 · TERMINATED
Trial details
- NCT number
- NCT02228785
- Sponsor
- Cancer Advances Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1994-05-01
- Primary completion
- 1994-10-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.